James E Flynn Insider Trading $ISTA ISTA PHARMACEUTICALS INC
Get free email notifications about insider trading for James E Flynn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James E Flynn. James E Flynn is 10% Owner in CAS MEDICAL SYSTEMS INC ($CAMY.OB) and 10% Owner in AxoGen, Inc. ($LECT) and 10% Owner in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and 10% Owner in Fibrocell Science, Inc. ($FCSC) and 10% Owner in STREAMLINE HEALTH SOLUTIONS INC. ($LANV) and 10% Owner in ANTARES PHARMA, INC. ($ATRS) and 10% Owner in VIA Pharmaceuticals, Inc. ($CAQ) and 10% Owner in DUSA PHARMACEUTICALS INC ($DUSA) and 10% Owner in HI TECH PHARMACAL CO INC ($HITK) and 10% Owner in AVADEL PHARMACEUTICALS PLC ($AVDL) and 10% Owner in INSPIRE PHARMACEUTICALS INC ($ISPH) and 10% Owner in RIGEL PHARMACEUTICALS INC ($RIGL) and 10% Owner in ARENA PHARMACEUTICALS INC ($ARNA) and 10% Owner in ISTA PHARMACEUTICALS INC ($ISTA) and 10% Owner in MEDICINES CO /DE ($MDCO) and 10% Owner in THIRD WAVE TECHNOLOGIES INC /WI ($TWTI) and 10% Owner in DYNAVAX TECHNOLOGIES CORP ($DVAX) and 10% Owner in Cyclacel Pharmaceuticals, Inc. ($CYCC) and Director in Talon Therapeutics, Inc. ($EMLR) and 10% Owner in LUMOS PHARMA, INC. ($NLNK) and 10% Owner in NITROMED INC ($NTMD) and 10% Owner in XENOPORT INC ($XNPT) and 10% Owner in EMAGEON INC ($EMAG) and 10% Owner in CATALYST BIOSCIENCES, INC. ($CBIO) and 10% Owner in ALIMERA SCIENCES INC ($ALIM) and 10% Owner in NeuroMetrix, Inc. ($NURO) and 10% Owner in NxStage Medical, Inc. ($NXTM) and 10% Owner in aTYR PHARMA INC ($LIFE) and 10% Owner in Vanda Pharmaceuticals Inc. ($VNDA) and 10% Owner in XERIS PHARMACEUTICALS INC ($XERS) and Director in PROTEON THERAPEUTICS INC ($PRTO) and 10% Owner in eHealth, Inc. ($EHTH) and 10% Owner in ZAFGEN, INC. ($ZFGN) and 10% Owner in NeurogesX Inc ($NGSX) and 10% Owner in Invuity, Inc. ($IVTY) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and 10% Owner in TriVascular Technologies, Inc. ($TRIV) and 10% Owner in Auspex Pharmaceuticals, Inc. ($ASPX) and 10% Owner in Neos Therapeutics, Inc. ($NEOS) and 10% Owner in Schrodinger, Inc. ($SDGR) and 10% Owner in CytomX Therapeutics, Inc. ($CTMX) and Director in Acutus Medical, Inc. ($AFIB) and 10% Owner in Annexon, Inc. ($ANNX) and 10% Owner in Aclaris Therapeutics, Inc. ($ACRS) and 10% Owner in Syros Pharmaceuticals, Inc. ($SYRS) and 10% Owner in Mallinckrodt plc ($MNK) and 10% Owner in Loxo Oncology, Inc. ($LOXO) and 10% Owner in Adverum Biotechnologies, Inc. ($AAVL) and 10% Owner in REGENXBIO Inc. ($RGNX) and 10% Owner in Recro Pharma, Inc. ($REPH) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and Director in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and 10% Owner in SteadyMed Ltd. ($STDY) and 10% Owner in ShockWave Medical, Inc. ($SWAV) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and 10% Owner in Editas Medicine, Inc. ($EDIT) and Director in AveXis, Inc. ($AVXS) and 10% Owner in ARVINAS INC. ($ARVN) and 10% Owner in Homology Medicines, Inc. ($FIXX) and Director in Homology Medicines, Inc. ($FIXX) and Director in Oncorus, Inc. ($ONCR) and 10% Owner in Revolution Medicines, Inc. ($RVMD) and 10% Owner in Black Diamond Therapeutics, Inc. ($BDTX) and 10% Owner in Frequency Therapeutics, Inc. ($FREQ) and Director in DFB Healthcare Acquisitions Corp. ($DFBH) and 10% Owner in Generation Bio Co. ($GBIO) and 10% Owner in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and 10% Owner in Cabaletta Bio, Inc. ($CABA) and 10% Owner in Werewolf Therapeutics, Inc. ($HOWL) and 10% Owner in Nkarta, Inc. ($NKTX) and 10% Owner in Edgewise Therapeutics, Inc. ($EWTX) and Director in DFP HEALTHCARE ACQUISITIONS CORP. ($DFPH) and Director in Deerfield Healthcare Technology Acquisitions Corp. ($DFHT) and 10% Owner in Terns Pharmaceuticals, Inc. ($TERN).
James E Flynn in ISTA PHARMACEUTICALS INC
Trading Symbol: ISTAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 551,099 shares
Latest Transaction: May 06 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of James E Flynn in ISTA PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACRS, AFIB, DFBH, ADVM, ALIM, ALPN, ANNX, ATRS, ARNA, ARVN, LIFE, BOLD, ASPX, AVDL, AVXS, LECT, BDTX, CABA, CAMY.OB, CBIO, CNST, CYCC, CTMX, DFHTW, DFPHU, DRNA, DUSA, DVAX, EWTX, EDIT, EHTH, EMAG, FCSC, FREQ, GBIO, HITK, FIXX, ISPH, IVTY, ISTA, KNSA, LRMR, LOXO, NLNK, MNK, MDCO, MIRM, NEOS, NGSX, NURO, NTMD, NKTX, NXTM, ONCR, PRX, TARA, REPH, RGNX, RVMD, RYTM, RIGL, SDGR, SWAV, STDY, LANV, SYRS, EMLR, TERN, TWTI, TRIV, VNDA, CAQ, HOWL, XNPT, XERS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 06 2011 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Sell | S | 10.60 | 135,036 | 1,431,382 | 551,099 | 686.1 K to 551.1 K (-19.68 %) |
May 06 2011 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Sell | S | 10.60 | 83,814 | 888,428 | 342,061 | 425.9 K to 342.1 K (-19.68 %) |
May 06 2011 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Sell | S | 10.60 | 39,916 | 423,110 | 162,917 | 202.8 K to 162.9 K (-19.68 %) |
May 06 2011 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Sell | S | 10.60 | 26,375 | 279,575 | 107,655 | 134 K to 107.7 K (-19.68 %) |
May 06 2011 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Sell | S | 10.50 | 52,551 | 551,786 | 686,135 | 738.7 K to 686.1 K (-7.11 %) |
May 06 2011 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Sell | S | 10.50 | 32,616 | 342,468 | 425,875 | 458.5 K to 425.9 K (-7.11 %) |
May 06 2011 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Sell | S | 10.50 | 15,535 | 163,118 | 202,833 | 218.4 K to 202.8 K (-7.11 %) |
May 06 2011 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Sell | S | 10.50 | 10,265 | 107,783 | 134,030 | 144.3 K to 134 K (-7.11 %) |
May 06 2011 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Sell | S | 10.54 | 478,946 | 5,048,091 | 738,686 | 1.2 M to 738.7 K (-39.33 %) |
May 06 2011 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Sell | S | 10.54 | 297,290 | 3,133,437 | 458,491 | 755.8 K to 458.5 K (-39.34 %) |
May 06 2011 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Sell | S | 10.52 | 328,995 | 3,461,027 | 218,368 | 547.4 K to 218.4 K (-60.11 %) |
May 06 2011 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Sell | S | 10.52 | 211,717 | 2,227,263 | 144,295 | 356 K to 144.3 K (-59.47 %) |
Jun 05 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.63 | 543 | 3,059 | 585,055 | 584.5 K to 585.1 K (+0.09 %) |
Jun 05 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.63 | 269 | 1,515 | 290,757 | 290.5 K to 290.8 K (+0.09 %) |
Jun 01 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.77 | 50,804 | 293,144 | 584,512 | 533.7 K to 584.5 K (+9.52 %) |
Jun 01 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.77 | 25,247 | 145,678 | 290,488 | 265.2 K to 290.5 K (+9.52 %) |
May 26 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.73 | 3,140 | 17,990 | 533,708 | 530.6 K to 533.7 K (+0.59 %) |
May 26 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.73 | 1,560 | 8,938 | 265,241 | 263.7 K to 265.2 K (+0.59 %) |
May 26 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.59 | 11,910 | 66,616 | 530,568 | 518.7 K to 530.6 K (+2.30 %) |
May 26 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.59 | 5,918 | 33,101 | 263,681 | 257.8 K to 263.7 K (+2.30 %) |
May 24 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.58 | 68,163 | 380,390 | 518,658 | 450.5 K to 518.7 K (+15.13 %) |
May 24 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.58 | 33,877 | 189,054 | 257,763 | 223.9 K to 257.8 K (+15.13 %) |
May 24 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.75 | 817 | 4,696 | 450,495 | 449.7 K to 450.5 K (+0.18 %) |
May 24 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.75 | 405 | 2,328 | 223,886 | 223.5 K to 223.9 K (+0.18 %) |
May 22 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.69 | 68,559 | 390,348 | 449,678 | 381.1 K to 449.7 K (+17.99 %) |
May 22 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.69 | 34,073 | 193,998 | 223,481 | 189.4 K to 223.5 K (+17.99 %) |
May 22 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.65 | 33,581 | 189,860 | 381,119 | 347.5 K to 381.1 K (+9.66 %) |
May 22 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.65 | 16,687 | 94,345 | 189,408 | 172.7 K to 189.4 K (+9.66 %) |
May 18 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.71 | 20,241 | 115,487 | 347,538 | 327.3 K to 347.5 K (+6.18 %) |
May 18 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.71 | 10,059 | 57,393 | 172,721 | 162.7 K to 172.7 K (+6.18 %) |
May 15 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.75 | 6,410 | 36,836 | 327,297 | 320.9 K to 327.3 K (+2.00 %) |
May 15 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.75 | 3,185 | 18,303 | 162,662 | 159.5 K to 162.7 K (+2.00 %) |
May 15 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.74 | 6,914 | 39,679 | 320,887 | 314 K to 320.9 K (+2.20 %) |
May 15 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.74 | 3,436 | 19,719 | 159,477 | 156 K to 159.5 K (+2.20 %) |
May 15 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.75 | 37,769 | 217,036 | 313,973 | 276.2 K to 314 K (+13.67 %) |
May 15 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.75 | 18,770 | 107,860 | 156,041 | 137.3 K to 156 K (+13.67 %) |
May 11 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.63 | 25,702 | 144,602 | 276,204 | 250.5 K to 276.2 K (+10.26 %) |
May 11 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.63 | 12,773 | 71,862 | 137,271 | 124.5 K to 137.3 K (+10.26 %) |
May 11 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.87 | 14,028 | 82,326 | 250,502 | 236.5 K to 250.5 K (+5.93 %) |
May 11 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.87 | 6,972 | 40,917 | 124,498 | 117.5 K to 124.5 K (+5.93 %) |
May 11 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.90 | 9,286 | 54,787 | 236,474 | 227.2 K to 236.5 K (+4.09 %) |
May 11 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.90 | 4,614 | 27,223 | 117,526 | 112.9 K to 117.5 K (+4.09 %) |
May 11 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.78 | 5,647 | 32,649 | 227,188 | 221.5 K to 227.2 K (+2.55 %) |
May 11 2006 | ISTA | ISTA PHARMACEUTICA ... | Flynn James E | 10% Owner | Buy | P | 5.78 | 2,806 | 16,223 | 112,912 | 110.1 K to 112.9 K (+2.55 %) |
Page: 1